{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:24:26Z","timestamp":1761017066399},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jns.2014.03.051","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T05:31:21Z","timestamp":1396503081000},"page":"147-149","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Levetiracetam as alternative treatment in Jeavons syndrome"],"prefix":"10.1016","volume":"341","author":[{"given":"D.","family":"Parissis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Karacostas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.jns.2014.03.051_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1528-1167.2009.02114.x","article-title":"Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions?","volume":"50","author":"Striano","year":"2009","journal-title":"Epilepsia"},{"year":"2005","series-title":"The epilepsies: seizures, syndromes and management","author":"Panayiotopoulos","key":"10.1016\/j.jns.2014.03.051_bb0010"},{"issue":"5","key":"10.1016\/j.jns.2014.03.051_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0987-7053(02)00343-X","article-title":"Eyelid myoclonia with absences: an overlooked epileptic syndrome?","volume":"32","author":"Striano","year":"2002","journal-title":"Neurophysiol Clin"},{"issue":"2","key":"10.1016\/j.jns.2014.03.051_bb0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.jns.2014.03.051_bb0025","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jns.2014.03.051_bb0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1528-1167.2007.01524.x","article-title":"A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome)","volume":"49","author":"Striano","year":"2008","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jns.2014.03.051_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11940-011-0131-z","article-title":"Treatment options in juvenile myoclonic epilepsy","volume":"13","author":"Mantoan","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jns.2014.03.051_bb0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","article-title":"Antimyoclonic effect of levetiracetam in 13 patients with Unverricht\u2013Lundborg disease: clinical observations","volume":"45","author":"Magaudda","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 9","key":"10.1016\/j.jns.2014.03.051_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1528-1167.2005.00315.x","article-title":"Photosensitivity in idiopathic generalized epilepsies","volume":"46","author":"Covanis","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2014.03.051_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yebeh.2009.07.033","article-title":"Differential effects of levetiracetam, carbamazepine and lamotrigine on reproductive endocrine function in adults","volume":"16","author":"Svalheim","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.jns.2014.03.051_bb0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2014.03.051_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1528-1167.2010.02897.x","article-title":"Antiepileptic drugs, sex hormones, and PCOS","volume":"52","author":"Verrotti","year":"2011","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"10.1016\/j.jns.2014.03.051_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jns.2014.03.051_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21411","article-title":"Hyperandrogenism, ovulatory dysfunction and polycystic ovary syndrome with valproate versus lamotrigine","volume":"64","author":"Morrell","year":"2008","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.jns.2014.03.051_bb0075","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T16:10:36Z","timestamp":1716653436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0022510X14002123"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.051","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam as alternative treatment in Jeavons syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}